Bhutan vs Equatorial Guinea: The number of people with susceptibility test result for rifampicin
Bhutan
419
in 2021
Equatorial Guinea
492
in 2021
Bhutan rank
83rd
Equatorial Guinea rank
80th
The number of people with susceptibility test result for rifampicin over time
- Bhutan
- Equatorial Guinea
How they compare
Equatorial Guinea currently reports 492 against 419 in Bhutan, a difference of 73.
That makes Equatorial Guinea's figure about 1.2 times Bhutan's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Bhutan ahead.
Bhutan ranks 83rd and Equatorial Guinea ranks 80th of 155 countries.
Bhutan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Equatorial Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 400.33 | 31.33 | 369 | Bhutan |
| 2020s | 426.5 | 371 | 55.5 | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bhutan or Equatorial Guinea?
- Equatorial Guinea, at 492 against 419 in Bhutan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bhutan and Equatorial Guinea?
- 73, with Equatorial Guinea ahead.
- How many years of comparable data are there for Bhutan and Equatorial Guinea?
- 5 years are reported by both, from 2017 to 2021.
- How do Bhutan and Equatorial Guinea rank globally for the number of people with susceptibility test result for rifampicin?
- Bhutan ranks 83rd and Equatorial Guinea ranks 80th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.